Document Detail


Limitations of the toxic equivalency factor approach for risk assessment of TCDD and related compounds.
MedLine Citation:
PMID:  9508738     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Halogenated aromatic hydrocarbons (HAHs), such as polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), and dibenzofurans (PCDFs), are industrial compounds or by-products that have been widely identified as environmental contaminants. Hazard and risk assessment of complex HAH mixtures have utilized a toxic equivalency factor (TEF) approach, where the toxic equivalents (TEQs) of any mixture are equal to the sum of the concentration of individual (i) congeners times their potencies (TEFi) relative to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, TEF = 1.0). TEQ = sigma [PCDDi] x TEFi + sigma [PCDFi] x TEFi + sigma [PCBi] x TEFi. The TEQ (or TCDD equivalents) can be readily calculated from analytical data and provides an estimate of the toxicity of any mixture containing HAHs. Several in vivo and in vitro studies with some PCDD/PCDF and PCB mixtures have demonstrated correlations between experimentally determined and calculated TEQs. However, results of several studies have also shown that for specific responses, the TEQ for some HAH mixtures are non-additive. For example, PCB mixtures and individual PCB congeners such as 2,2',4,4',5,5'-hexachlorobiphenyl inhibit toxic and biochemical responses induced by TCDD and related compounds. Another problem associated with hazard and risk assessment of background exposure to HAHs is the relative contribution of trace levels of HAHs (exodioxins) compared to relatively high exposure to naturally occurring aryl hydrocarbon receptor (AhR) agonists, which act through the same mechanistic pathway.
Authors:
S Safe
Related Documents :
12396678 - The belgian pcb/dioxin incident: a critical review of health risks evaluations.
18068298 - Polychlorinated dibenzo-p-dioxins/dibenzofurans distributions in ash from different uni...
15260318 - Pcb loading from sediment in the hudson river: congener signature analysis of pathways.
18599108 - Polybrominated diphenyl ethers (pbde) in serum: findings from a us cohort of consumers ...
3744888 - Energy expenditure of young men from obese and non-obese families.
17188208 - Survival of helicobacter pylori in artificially contaminated ultrahigh temperature and ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Teratogenesis, carcinogenesis, and mutagenesis     Volume:  17     ISSN:  0270-3211     ISO Abbreviation:  Teratog., Carcinog. Mutagen.     Publication Date:    1997-1998
Date Detail:
Created Date:  1998-03-19     Completed Date:  1998-03-19     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8100917     Medline TA:  Teratog Carcinog Mutagen     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  285-304     Citation Subset:  IM    
Affiliation:
Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station 77843-4466, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Benzofurans / toxicity
Humans
Receptors, Aryl Hydrocarbon / agonists
Risk Assessment*
Tetrachlorodibenzodioxin / toxicity*
Grant Support
ID/Acronym/Agency:
P42-ES04917/ES/NIEHS NIH HHS
Chemical
Reg. No./Substance:
0/Benzofurans; 0/Receptors, Aryl Hydrocarbon; 0/chlorinated dibenzofurans; 1746-01-6/Tetrachlorodibenzodioxin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immunotoxic effects of TCDD and toxic equivalency factors.
Next Document:  Implantation of elastic intraocular lenses in traumatic cataracts